Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel S Lenchner

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
NPJ Precision Oncology|January 5, 2024
A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibitionDaniel S Lenchner, Zaritza O Petrova, Lisa Hunihan, et al.
NPJ Precision Oncology|July 4, 2025
Genetic and oncogenic features of RASGRF fusionsSreya Das, Daniel S Lenchner, Ellen Jaeger, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
NPJ Precision Oncology|January 5, 2024
A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibitionDaniel S Lenchner, Zaritza O Petrova, Lisa Hunihan, et al.
NPJ Precision Oncology|July 4, 2025
Genetic and oncogenic features of RASGRF fusionsSreya Das, Daniel S Lenchner, Ellen Jaeger, et al.
Pageof 1